Cargando…

Severe Potential Drug-Drug Interactions and the Increased Length of Stay of Children in Intensive Care Unit

Children are exposed to drug-drug interactions (DDI) risks due to their organism’s complexity and the need for several medicines prescriptions in pediatric intensive care units (PICU). This study aimed to assess the prevalence of potential DDIs in a Brazilian PICU. We carried out a cross-sectional s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lima, Elisangela da Costa, Camarinha, Barbara Dias, Ferreira Bezerra, Nathalia Cristina, Panisset, Anderson Gonçalves, Belmino de Souza, Raquel, Silva, Marcus Tolentino, Lopes, Luciane Cruz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744879/ https://www.ncbi.nlm.nih.gov/pubmed/33343344 http://dx.doi.org/10.3389/fphar.2020.555407

Ejemplares similares

Sales trends of psychotropic drugs in the COVID-19 pandemic: A national database study in Brazil
por: Del Fiol, Fernando de Sá, et al.
Publicado: (2023)

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

Multisystem inflammatory syndrome drug treatment in countries with different income profiles: a scoping review
por: Nagem Lopes, Luis Phillipe, et al.
Publicado: (2023)

Editorial: Evidence for Assessing Drug Safety and Drug Use in Older People
por: Lopes, Luciane Cruz, et al.
Publicado: (2022)

Data Sources for Drug Utilization Research in Brazil—DUR-BRA Study
por: Leal, Lisiane Freitas, et al.
Publicado: (2022)

Frequency and Severity of Adverse Drug Reactions to Medications Prescribed for Alzheimer’s Disease in a Brazilian City: Cross-Sectional Study
por: Ferreira, Tânia Regina, et al.
Publicado: (2020)

Editorial: New Horizons in Health-Promoting Technologies: From Development to Rational Use
por: Lopes, Luciane Cruz, et al.
Publicado: (2020)

Drug utilization research in Peru: Is real-world data available?
por: Rodríguez-Tanta, L. Yesenia, et al.
Publicado: (2023)

Consumption Trends of Antibiotics in Brazil During the COVID-19 Pandemic
por: Del Fiol, Fernando de Sá, et al.
Publicado: (2022)

Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study
por: Pedroso, José Victor de Miranda, et al.
Publicado: (2021)

The High “Cost” of Experimental Drugs Obtained Through Health Litigation in Brazil
por: da Silva, Ricardo Eccard, et al.
Publicado: (2020)

Kawasaki Disease and the Use of the Rotavirus Vaccine in Children: A Systematic Review and Meta-Analysis
por: Mellone, Natália Gibim, et al.
Publicado: (2019)

Length of Hospital Stay and Bed Occupancy Rates in Former Yugoslav Republics 1989–2015
por: Cvetkovic, Aleksandar, et al.
Publicado: (2016)

Editorial: New Horizons in Health-Promoting: From Methods to Implementation Science
por: Barberato-Filho, Silvio, et al.
Publicado: (2022)

Serious Adverse Drug Reactions and Safety Signals in Children: A Nationwide Database Study
por: Vieira, Jean Mendes de Lucena, et al.
Publicado: (2020)

Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System
por: Barcelos, Flávia Campos, et al.
Publicado: (2019)

Glutamatergic transmission in drug reward: implications for drug addiction
por: D'Souza, Manoranjan S.
Publicado: (2015)

A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir / Ritonavir
por: Zheng, Jiantao, et al.
Publicado: (2023)

Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting
por: de Camargo, Mayara Costa, et al.
Publicado: (2019)

Associations of Fentanyl, Sufentanil, and Remifentanil With Length of Stay and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study
por: Wang, Wen, et al.
Publicado: (2022)

Strategies to Approach Medicines Litigation: An Action Research Study in Brazil
por: Machado, Fernanda Lacerda da Silva, et al.
Publicado: (2021)

Long-term benzodiazepine use in patients taking antidepressants in a public health setting in Brazil: a cross-sectional study
por: Fulone, Izabela, et al.
Publicado: (2018)

Late adverse effects related to treatment in a cohort of survivors of childhood and adolescent cancer
por: Livinalli, Annemeri, et al.
Publicado: (2019)

Gender differences in the use of atypical antipsychotics in early-onset schizophrenia: a nationwide population-based study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017
por: Fulone, Izabela, et al.
Publicado: (2023)

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
por: Létinier, Louis, et al.
Publicado: (2021)

Analysis of Hospitalization Length of Stay and Total Charges for Patients with Drug Abuse Comorbidity
por: Ndanga, Memory, et al.
Publicado: (2019)

The Impact of Drug Interactions in Patients with Community-Acquired Pneumonia on Hospital Length of Stay
por: Schmitt, Johannes Peter, et al.
Publicado: (2022)

Chemoinformatics Strategies for Leishmaniasis Drug Discovery
por: Ferreira, Leonardo L. G., et al.
Publicado: (2018)

Factors associated with the length of hospital stay of women undergoing cesarean section
por: Pereira, Samire Lopes, et al.
Publicado: (2019)

Prolonged length of stay in acute psychiatric wards: A descriptive study
por: Lopes, L., et al.
Publicado: (2021)

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
por: Létinier, Louis, et al.
Publicado: (2019)

Identifying problematic drugs based on the characteristics of their targets
por: Lopes, Tiago J. S., et al.
Publicado: (2015)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)

Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects
por: Mallikaarjun, Suresh, et al.
Publicado: (2016)

Strategies Implemented by Public Institutions to Approach the Judicialization of Health Care in Brazil: A Systematic Scoping Review
por: Yamauti, Sueli Miyuki, et al.
Publicado: (2020)

Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals
por: Acton, Emily K., et al.
Publicado: (2022)

Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug–Drug and Drug–Disease Interactions of Apatinib
por: Liu, Hongrui, et al.
Publicado: (2021)

Prediction of the Drug–Drug Interaction Types with the Unified Embedding Features from Drug Similarity Networks
por: Yan, Xiao-Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_63goqt55pgb25djbd1l8k56t36